The clinical basis.
Published thresholds, population-specific criteria and evidence-supported interpretations.
A defined scope. An explicit methodology.
Everra is designed to connect cardiometabolic findings through explicit clinical rules and synthesis methods, with the basis available for clinician review.
Explore the review approach ↓Initial clinical scope
Everra’s initial scope covers cardiovascular, metabolic, lipid, inflammatory, autonomic and sleep findings. Its synthesis methodology defines when those findings can be connected.
Evidence and Everra methodology
Published thresholds, population-specific criteria and evidence-supported interpretations.
Resolution and pattern activation, prioritization and longitudinal synthesis, and cross-domain interpretation.
Traceability is intended to reconstruct what produced the interpretation. Determinism means the same inputs and versions produce the same result. Neither, by itself, establishes clinical usefulness.
Inside the synthesis step
The methodology addresses overlapping findings, pattern formation, change over time and cross-domain relationships. Each important synthesis decision should be explicit and open to review.
Handle overlapping or competing findings.
Establish when findings support a pattern.
Interpret comparable observations over time.
Connect findings only when justified.
Separate normal findings from not enough information.
Three related questions
Substantial clinical-rule review work includes sources, reviewer decisions, audits and version history. Closeout remains in progress.
The proposed informatics review focuses on overlap, pattern formation, change over time, cross-domain links, missingness and uncertainty.
The meaning of a composite number, its combination and weighting, and validation for its intended use are separate from review of the individual rules.
These workstreams are not interchangeable. Repeatability and backward traceability are also technical implementation checks—not substitutes for clinical validation.
Review status: 11 September 2026. Clinical-rule review, synthesis review and score validation are distinct. Completed clinical validation is not claimed.
A considered evaluation
Discuss coherence, justification, evaluation needs and priorities before a clinical pilot.